Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

BMDC treated with I-BET151 and sitmulated with IgG immune complex

ABSTRACT: Bone marrow derived dendritic cells were cultured and stimulated with I-BET151 or DMSO control, and stimulated with Ovalbumin-IgG immune complex or Ovalbumin control.

ORGANISM(S): Mus musculus

PROVIDER: GSE200226 | GEO | 2022/05/02

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

BMDM treated with I-BET151 and sitmulated with IgG immune complex

Project description:Bone marrow derived macrophages were cultured and stimulated with I-BET151 or DMSO control, and stimulated with Ovalbumin-IgG immune complex or Ovalbumin control.

2022-05-02 | GSE200033 | GEO

BMDC treated with I-BET151 and sitmulated with IgG immune complex

Project description:BMDC treated with I-BET151 and sitmulated with IgG immune complex

| PRJNA823712 | ENA

BMDM treated with I-BET151 and sitmulated with IgG immune complex

Project description:BMDM treated with I-BET151 and sitmulated with IgG immune complex

| PRJNA822764 | ENA

Treatment of myeloma cell lines with the bromodomain inhibitor I-BET151

Project description:KMS12BM and H929 myeloma cells were treated in vitro with either I-BET151 1uM or vehicle (DMSO) for 6 hours (n=3 independent experiments for each cell line). Total RNA was extracted from H929 and KMS12BM cells using the RNeasy Mini kit (Qiagen). Genomic DNA contamination was eliminated using columns (Qiagen) and DNAase digestion. The extracted RNA was quantified in a Nanodrop, while purity and integrity was confirmed on an Agilent 2100 Bioanalyser with RNA Nano Chips. cDNA was produced from 150ng total RNA input, using the Ambion WT Expression Kit. The cDNA was then fragmented and labelled using the GeneChip WT Terminal Labelling Kit (Affymetrix) and hybridised on Human Gene ST1.0 Arrays (Affymetrix) on a GeneChip Fluidics Station 450. The arrays were scanned in a GeneChip Scanner 3000 7G with autoloader.

2013-12-22 | E-MTAB-2122 | biostudies-arrayexpress

Genetic differences in conditioned medium through adding human AQP4-IgG on primary astrocytes.

Project description:To investigate the genetic differencesin human AQP4-IgG group and control-IgG group , we established primary astrocytes line. We then performed gene expression profiling analysis using data obtained from RNA-seq after 48h with stimulation with human AQP4-IgG and control-IgG.

2023-04-12 | GSE229365 | GEO

IgG control ChIP in HeLa cells

Project description:Control IgG ChIP vs matched total for HeLa cells. Three biological replicates. Keywords: ChIP-chip

2006-03-09 | GSE4338 | GEO

IgG control ChIP in HeLa cells

Project description:Control IgG ChIP vs matched total for HeLa cells. Three biological replicates. ChIP-chip of IgG; look for non-specific binding sites.

2010-07-01 | E-GEOD-4338 | biostudies-arrayexpress

Protein arginine methyltransferase 5 (PRMT5) is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer

Project description:PRMT5 Co-IP mass spectrometry: Lysates of MCF-7 RB1-knockout cells were pulled down with a PRMT5 antibody or IgG control. The pulldowns were subjected to mass spectrometry analysis. QEX2_981005, QEX2_981006, QEX2_981007: DMSO, IgG QEX2_981008, QEX2_981009, QEX2_981010: DMSO, PRMT5 antibody QEX2_981011, QEX2_981012, QEX2_981013, GSK, IgG QEX2_981014, QEX2_981015, QEX2_981016, GSK, PRMT5 antibody SDMA PTM analysis: MCF-7 RB1-knockout cells were transfected with a PRMT5 siRNA or a control siRNA. Lysates were collected three days after transfection and subjected to mass spectrometry analysis. LUM1_1000791, LUM1_1000792, LUM1_1000793: control SiRNA LUM1_1000794, LUM1_1000795, LUM1_1000796: PRMT5 siRNA [

2024-01-12 | PXD046996 | Pride

Intact Transition Epitope Mapping – Serological Inspection by Epitope EXtraction (ITEM – SIX)

Project description:Precision medicine requests accurate serological inspections to precisely stratify patients for targeted treatment. Intact transition epitope mapping analysis proved seroconversion of a model organism's serum when spiked with a monoclonal murine anti-ovalbumin antibody with epitope-resolution. Isolation of the IgG fraction from blood serum applied two consecutive protein precipitation steps followed by ultrafiltration and resulted in an ESI-MS analysis-ready IgG preparation. For epitope mapping by epitope extraction, the ovalbumin antigen was digested with trypsin. After desalting, the peptide mixture was added to the ESI-MS-ready IgG preparation from converted serum and the solution was incubated to form an immune complex between the ovalbumin-derived epitope peptide and the anti-ovalbumin antibody. Then, the entire mixture of proteins and peptides was directly electrosprayed. Sorting of ions in the mass spectrometer's gas phase, dissociation of the immune complex ions by collision induced dissociation, and recording of the epitope peptide ion which had been released from the immune complex revealed the presence of the anti-ovalbumin antibody in converted serum. Mass determination of the complex-released epitope peptide ion with isotope resolution is highly accurate, guaranteeing high specificity of this novel seroconversion analysis approach which is termed Intact Transition Epitope Mapping – Serological Inspections by Epitope EXtraction (ITEM – SIX).

2023-03-31 | PXD040754 | Pride

MiRNA-127 Inhibits IgG Immune Complex-induced Lung Inflammation by Targeting IgG Fcγ Receptor I

Project description:The molecular mechanisms of acute lung injury are incompletely understood. MicroRNAs (miRNAs) are crucial biological regulators that act by suppressing their target genes and are involved in a variety of pathophysiologic processes. MiR-127 appeared to be down-regulated during lung injury. We set out to investigate the role of miR-127 in lung injury and inflammation. Expression of miR-127 significantly reduced cytokine release by macrophages. Looking into the mechanisms of the regulation of inflammation by miR-127, we found that IgG Fcγ Receptor I (FcγRI/CD64) was a target of miR-127, as evidenced by reduced CD64 protein expression in macrophages over-expressing miR-127. Furthermore, miR-127 significantly reduced the luciferase activity with a reporter construct containing the native 3’-UTR of CD64. Importantly, we demonstrated that miR-127 attenuated lung inflammation in an IgG immune complex (IgG IC) model in vivo. Collectively, these data show that miR-127 targets macrophage CD64 expression and promotes the reduction of lung inflammation. Understanding how miRNAs regulate lung inflammation may represent an attractive way to control inflammation induced by infectious or non-infectious lung injury.

2012-04-04 | GSE27642 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data